BrightAccountsProduction v1.0.0 v1.0.0 2023-12-18 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The Principal Activity is that of a Holding Company. 31 August 2025 0 15359459 2024-12-31 15359459 2023-12-17 15359459 2023-12-18 2024-12-31 15359459 uk-bus:PrivateLimitedCompanyLtd 2023-12-18 2024-12-31 15359459 uk-curr:PoundSterling 2023-12-18 2024-12-31 15359459 uk-bus:FullAccounts 2023-12-18 2024-12-31 15359459 uk-bus:CompanySecretaryDirector1 2023-12-18 2024-12-31 15359459 uk-bus:CompanySecretary1 2023-12-18 2024-12-31 15359459 uk-bus:RegisteredOffice 2023-12-18 2024-12-31 15359459 uk-core:ShareCapital 2024-12-31 15359459 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2024-12-31 15359459 uk-bus:FRS102 2023-12-18 2024-12-31 15359459 uk-core:CurrentFinancialInstruments 2024-12-31 15359459 2023-12-18 2024-12-31 15359459 uk-bus:AuditExempt-NoAccountantsReport 2023-12-18 2024-12-31 xbrli:pure iso4217:GBP xbrli:shares

AI CARE SEC LIMITED

Director's Report and Unaudited Financial Statements

for the financial period from 18 December 2023 (date of incorporation) to 31 December 2024

AI CARE SEC LIMITED

DIRECTOR AND OTHER INFORMATION

Director | Mr Gareth O'Connell (Appointed 18 December 2023)
Company Secretary | Mr Gareth O'Connell
Company Registration Number | 15359459
Registered Office and Business Address | Unit 13b Boundary Business Centre Boundary Way
| Woking
| GU21 5DH
| United Kingdom
| 185 Rathmines Road Lower
| Dublin 6
| Republic of Ireland

AI CARE SEC LIMITED

DIRECTOR'S REPORT

for the financial period from 18 December 2023 (date of incorporation) to 31 December 2024

The director presents their report and the unaudited financial statements for the financial period from 18 December 2023 (date of incorporation) to 31 December 2024.

Principal Activity

The Principal Activity is that of a Holding Company.

Director

The director who served during the financial period is as follows:

Mr Gareth O'Connell (Appointed 18 December 2023)

There were no changes in shareholdings between 31 December 2024 and the date of signing the financial statements.

Political Contributions

The company did not make any disclosable political donations in the current financial period.

Statement of Director's Responsibilities

The director is responsible for preparing the Director's Report and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" Section 1A (Small Entities). Under company law the director must not approve the financial statements unless they is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to:

■ | select suitable accounting policies and apply them consistently;
■ | make judgements and accounting estimates that are reasonable and prudent;
■ | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Special provisions relating to small companies

The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.

On behalf of the board

___________________________

Mr Gareth O'Connell

Director

31 August 2025

AI CARE SEC LIMITED

PROFIT AND LOSS ACCOUNT

for the financial period from 18 December 2023 (date of incorporation) to 31 December 2024

|  | Dec 24
| Notes | £

Profit before taxation |  | -
Tax on profit |  | -
|  | ─────────
Profit for the financial period |  | -
|  | ─────────
Total comprehensive income |  | -
|  | ═════════

AI CARE SEC LIMITED

Company Registration Number: 15359459

BALANCE SHEET

as at 31 December 2024

|  |  | Dec 24
|  | Notes | £
Current Assets

Debtors |  | 7 | 100
|  |  | ─────────
Net Current Assets |  |  | 100
|  |  | ─────────
Total Assets less Current Liabilities |  |  | 100
|  |  | ═════════
Capital and Reserves

Called up share capital |  |  | 100
|  |  | ─────────
Equity attributable to owners of the company |  |  | 100
|  |  | ═════════
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).

For the financial period from 18 December 2023 (date of incorporation) to 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial period in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial period and of its profit and loss for the financial period in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Approved by the Director and authorised for issue on 31 August 2025

________________________________ |  |  |
Mr Gareth O'Connell |  |  |
Director |  |  |

AI CARE SEC LIMITED

NOTES TO THE FINANCIAL STATEMENTS

for the financial period from 18 December 2023 (date of incorporation) to 31 December 2024

1. | General Information
| AI CARE SEC LIMITED is a company limited by shares incorporated and registered in the United Kingdom. The registered number of the company is 15359459. The registered office of the company is Unit 13b Boundary Business Centre Boundary Way, Woking, GU21 5DH, United Kingdom which is also the principal place of business of the company. The nature of the company's operations and its principal activities are set out in the Director's Report. The financial statements have been presented in Pound (£) which is also the functional currency of the company.

2. | Summary of Significant Accounting Policies
| The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
| Statement of compliance
| The financial statements of the company for the financial period ended 31 December 2024 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006. These are the company's first set of financial statements prepared in accordance with FRS 102.
| Basis of preparation
| The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
| Trade and other debtors
| Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
| Employee benefits
| The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The company also operates a defined benefit pension scheme for its employees providing benefits based on final pensionable pay. The assets of this scheme are also held separately from those of the company, being invested with pension fund managers.
| Taxation and deferred taxation
| Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial period and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date. Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date.
| Foreign currencies
| Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Balance Sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Profit and Loss Account.
| Ordinary share capital
| The ordinary share capital of the company is presented as equity.

3. | Adoption of FRS 102 Section 1A
| This is the first set of financial statements prepared by AI CARE SEC LIMITED in accordance with accounting standards issued by the Financial Reporting Council, including FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” Section 1A (Small Entities). The company transitioned from previously extant Irish and UK GAAP to FRS 102 Section 1A as at 1 January 2016.

4. | Period of financial statements
| The financial statements are for the 12 month 14 days period from 18 December 2023 (date of incorporation) to 31 December 2024.

5. | Statement on previous periods
| The company did not present financial statements for previous periods.

6. | Employees
| The average monthly number of employees, including director, during the financial period was 0, (Dec 23 - 0).

7. | Debtors | Dec 24
|  | £
| Other debtors | 100
|  | ═════════

8. | Capital commitments
| The company had no material capital commitments at the financial period-ended 31 December 2024.

9. | Post-Balance Sheet Events
| There have been no significant events affecting the company since the financial period-end.